about
Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and DevelopmentStroke, dementia, and drug deliveryDrugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysisClinical and biochemical correlates of serum L-ergothioneine concentrations in community-dwelling middle-aged and older adultsTemporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data.Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data.An early drop in systolic blood pressure predicts a positive tilt table test in elderly patients with unexplained falls or syncope.Guideline for the diagnosis and management of hypertension in adults - 2016.Proton pump inhibitors and risk of readmission and mortality in older patients discharged from a tertiary hospital to residential aged care facilitiesHuman dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study.Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran communityPharmacovigilance and pharmacogenetic discussions at WorldPharma 2010.Drug safety advances from ICPE 2010.Latest drug safety alerts from the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.Minimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycleAssociations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients.Drug Burden Index in older adults: theoretical and practical issues.Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy.Online survey on subjective and objective competency in clinical pharmacology skills among final year Australian medical students: a pilot studyTargeting precision medicine toxicity: recent developments.The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.Geriatric medicine in an aging society: up for a challenge?The cardiovascular system.Non-steroidal anti-inflammatory drug (NSAID) related inhibition of aldosterone glucuronidation and arterial dysfunction in patients with rheumatoid arthritis: a cross-sectional clinical studyAge-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.Optimization of drug prescribing.Profound weight loss associated with reboxetine use in a 44-year-old woman.The implications of a growing evidence base for drug use in elderly patients Part 2. ACE inhibitors and angiotensin receptor blockers in heart failure and high cardiovascular risk patients.The implications of a growing evidence base for drug use in elderly patients. Part 3. Beta-adrenoceptor blockers in heart failure and thrombolytics in acute myocardial infarction.The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention.Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime?Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD.Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.Prokinetic therapy with erythromycin has no significant impact on blood pressure and heart rate in critically ill patientsSerum thiols and cardiovascular risk scores: a combined assessment of transsulfuration pathway components and substrate/product ratios.Sex differences in the response to resistance exercise training in older people.Relationship between Vitamin D Status and Autonomic Nervous System ActivityEffects of Ramipril and Telmisartan on Plasma Concentrations of Low Molecular Weight and Protein Thiols and Carotid Intima Media Thickness in Patients with Chronic Kidney DiseasePatterns of Drug Use and Serum Sodium Concentrations in Older Hospitalized Patients: A Latent Class Analysis Approach.
P50
Q28070134-073F1E04-F54A-4C12-800F-3F5A6912CA4FQ28166505-6E16CA62-D52D-4A50-8315-B0B1FD3F2E8EQ28258219-ACC99096-5506-4008-B6D2-2A1A5AC5420DQ28538290-A5C7EB24-4594-40DF-ADB9-C09032F73337Q30714318-2A6463EB-4AD9-482F-8F48-0F2A2367E7ACQ31102468-1D257CFB-31AA-492E-806C-70618C73963FQ33153591-0251722E-AECA-4A64-B702-A91D7190D8A5Q33167507-27A1BE72-188E-4582-843C-88456FD029A7Q33572611-6BF524BA-ACDB-435B-896B-BB08097065B8Q33767571-F17A005E-CE06-43AC-A918-D8307B545646Q33790456-88D8A86D-C0BD-4F21-A345-3C1A681F88D2Q33906348-405081C0-6A65-4B9E-A13F-C84A7CE5448DQ33949193-CC612E00-77E5-41AC-B763-B8574CE3DBF8Q33949233-C9CCB69C-A841-4F98-A014-2C5463C066F9Q33949336-39BB2179-7341-4957-BBF6-2188C4157CD1Q33949454-58667795-1F1B-48E8-A0F1-3CDBB66112DEQ34016202-634CB2CE-9404-4A8F-9A75-A9DEACEECBD3Q34198674-FCDD0275-1FDF-48F8-AE44-01DEB12A3CE0Q34286825-5E4568D7-38C9-4014-9024-1A3DA34EC22AQ34383584-51C441FE-BB48-477F-B3DE-4D1F1EC8245CQ35019470-39B30BBF-0BC4-4C49-BFCD-0F2E40D8D1ECQ35092457-3DDEF16B-B26A-486C-B5F1-61443410F050Q35104440-5D648897-8861-4D50-9105-01A1E5F99FB3Q35200046-4EB986A2-CE9D-41E2-B3E6-9046E93B68D9Q35320084-793597CA-D3D6-4D0F-8639-018EA5FB0D7CQ35608904-B6EF56DE-DAEE-4BED-8BAC-B671FA672E65Q35681265-92DDE8DF-000B-42DE-B2B6-86666A163CB5Q35827161-A813B0B0-C813-4C4A-AC41-9798EEC9E9E7Q35827554-FF80DADA-63C9-4F16-A6FA-B1870284A6E6Q35827573-5CCA6E5D-643F-4DE8-AFF2-31362B1499CAQ35827593-0B7D43E4-CDB1-45E4-901F-3F3D2E795C13Q35827683-8570D3CC-742E-4CD6-960B-F373AEF65C8FQ36091725-0B52EE95-5DA7-42F8-893F-5B3744F908CFQ36285871-3F6217DC-5B8D-4F34-8F0F-6C7A1765C8D3Q36388034-D70080B9-299C-475A-A77E-231FDDAD7944Q36798688-00987466-F338-4371-9431-8E71A15D1D5FQ37043356-447C38FD-56F6-4F3E-BFAF-A15CDF2B4E17Q37285881-449E21D9-2290-41BC-BBF2-0D27BB17675FQ37416423-A14ACC7E-137A-43BE-AC9E-A65F8BB41715Q37452828-FBA853E0-C43A-4C39-8091-9A487AA33FC2
P50
description
researcher ORCID ID = 0000-0001-8699-1412
@en
name
Arduino A Mangoni
@ast
Arduino A Mangoni
@en
Arduino A Mangoni
@nl
type
label
Arduino A Mangoni
@ast
Arduino A Mangoni
@en
Arduino A Mangoni
@nl
prefLabel
Arduino A Mangoni
@ast
Arduino A Mangoni
@en
Arduino A Mangoni
@nl
P31
P496
0000-0001-8699-1412